IM Cannabis
IM Cannabis Corp. is an international medical cannabis company based in Tel Aviv, Israel, founded in 2010 by Oren Shuster and Rafael Gabay. The company specializes in the breeding, cultivation, and distribution of medical cannabis products, primarily serving patients in Israel and Germany. Its product offerings include various strains and oils, as well as research and development of new genetic strains. IM Cannabis also provides intellectual property services related to the medical cannabis industry. The majority of its revenue is derived from sales in Israel, with additional income generated from its operations in Germany.
Oranim Pharm
Acquisition in 2022
Oranim Pharm is one of the largest pharmacies specializing in medical cannabis in Israel. It operates a network of pharmacies primarily in Jerusalem, offering a diverse range of products that include medical cannabis, fertility drugs, over-the-counter medications, nutritional supplements, vitamins, body care items, toiletries, and oral health products. This extensive selection enables individuals to access a variety of medicines and health-related items conveniently.
MYM Nutraceuticals
Acquisition in 2021
MYM Nutraceuticals Inc. is a Canadian company engaged in the cultivation, processing, and distribution of cannabis products. Established in 2014 and headquartered in Vancouver, the company focuses on acquiring Health Canada licenses to produce and market high-quality organic medicinal cannabis supplements and topical products. MYM operates two large-scale production projects in Québec, which, upon completion, will provide over 1.5 million square feet of production space. The company is also involved in various stages of the cannabis supply chain, including retail, processing, and product infusion, emphasizing the use of cannabis for healthcare purposes.
Trichome Financial
Acquisition in 2020
Trichome Financial is a specialty finance company based in Ontario, Canada, established on January 24, 2018, to address the financing challenges faced by the legal cannabis industry. Focused on providing flexible and creative capital solutions, Trichome offers customized financing to companies across the cannabis value chain, supporting needs such as growth, capital expenditures, mergers and acquisitions, working capital, and bridge loans. The firm benefits from the expertise and resources of its founders, Origin House and Stoic Advisory, enabling it to capitalize on proprietary deal flow and industry insights. While Trichome's current assets are concentrated in Canada, the company has positioned itself as a key player in the evolving cannabis market by delivering significant value-added financial and operational support to its partners.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.